NIAID Banner Logo Image

HIV Citation List: April 27 - May 10, 2012

Pubmed citations

1. Synthesis and Biological Evaluation of Fatty Acyl Ester Derivatives of (-)-2',3'-Dideoxy-3'-thiacytidine. Agarwal, H.K., B.S. Chhikara, M.J. Hanley, G. Ye, G.F. Doncel, and K. Parang, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22533850].

[PubMed]. HIV_0427-051012.

2. Synthesis and Structure-Activity Relationship Studies of HIV-1 Virion Infectivity Factor (Vif) Inhibitors That Block Viral Replication. Ali, A., J. Wang, R.S. Nathans, H. Cao, N. Sharova, M. Stevenson, and T.M. Rana, ChemMedChem, 2012. [Epub ahead of print]; PMID[22555953].

[PubMed]. HIV_0427-051012.

3. Histone Methyltransferase Inhibitors Induce HIV-1 Recovery in Resting CD4+ T Cells from HIV-1+ HAART-treated Patients. Bouchat, S., J.S. Gatot, K. Kabeya, C. Cardona, L. Colin, G. Herbein, S. de Wit, N. Clumeck, O. Lambotte, C. Rouzioux, O. Rohr, and C. van Lint, AIDS, 2012. [Epub ahead of print]; PMID[22555163].

[PubMed]. HIV_0427-051012.

4. Single-domain Antibody-SH3 Fusions for Efficient Neutralization of HIV-1 Nef Functions. Bouchet, J., C. Herate, C.A. Guenzel, C. Verollet, A. Jarviluoma, J. Mazzolini, S. Rafie, P. Chames, D. Baty, K. Saksela, F. Niedergang, I. Maridonneau-Parini, and S. Benichou, Journal of Virology, 2012. 86(9): p. 4856-4867; PMID[22345475].

[PubMed]. HIV_0427-051012.

5. Monoclonal Antibody-based Candidate Therapeutics against HIV Type 1. Chen, W. and D.S. Dimitrov, AIDS Research and Human Retroviruses, 2012. 28(5): p. 425-434; PMID[21827278].

[PubMed]. HIV_0427-051012.

6. Synthesis and Biological Evaluation of Piperidine-substituted Triazine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Chen, X., P. Zhan, C. Pannecouque, J. Balzarini, E. De Clercq, and X. Liu, European Journal of Medicinal Chemistry, 2012. 51: p. 60-66; PMID[22405288].

[PubMed]. HIV_0427-051012.

7. Protein Kinase C-delta Regulates HIV-1 Replication at an Early Post-entry Step in Macrophages. Contreras, X., O. Mzoughi, F. Gaston, B.M. Peterlin, and E. Bahraoui, Retrovirology, 2012. 9(1): p. 37; PMID[22554282].

[PubMed]. HIV_0427-051012.

8. Polyvalent Side Chain Peptide-synthetic Polymer Conjugates as HIV-1 Entry Inhibitors. Danial, M., M.J. Root, and H.A. Klok, Biomacromolecules, 2012. [Epub ahead of print]; PMID[22455441].

[PubMed]. HIV_0427-051012.

9. Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1. Dogo-Isonagie, C., S. Lam, E. Gustchina, P. Acharya, Y. Yang, S. Shahzad-Ul-Hussan, G.M. Clore, P.D. Kwong, and C.A. Bewley, Journal of Biological Chemistry, 2012. 287(18): p. 15076-15086; PMID[22403408].

[PubMed]. HIV_0427-051012.

10. Design, Synthesis, and Biological Activity of Novel 1,4-Disubstituted Piperidine/Piperazine Derivatives as CCR5 Antagonist-based HIV-1 Entry Inhibitors. Dong, M.X., L. Lu, H. Li, X. Wang, H. Lu, S. Jiang, and Q.Y. Dai, Bioorganic & Medicinal Chemistry Letters, 2012. 22(9): p. 3284-3286; PMID[22464131].

[PubMed]. HIV_0427-051012.

11. Galectin-9 Binding to Tim-3 Renders Activated Human CD4+ T Cells Less Susceptible to HIV-1 Infection. Elahi, S., T. Niki, M. Hirashima, and H. Horton, Blood, 2012. 119(18): p. 4192-4204; PMID[22438246].

[PubMed]. HIV_0427-051012.

12. Susceptibility of HIVType 2 Primary Isolates to CCR5 and CXCR4 Monoclonal Antibodies, Ligands, and Small Molecule Inhibitors. Espirito-Santo, M., Q. Santos-Costa, M. Calado, P. Dorr, and J.M. Azevedo-Pereira, AIDS Research and Human Retroviruses, 2012. 28(5): p. 478-485; PMID[21902586].

[PubMed]. HIV_0427-051012.

13. Design of a Modular Tetrameric Scaffold for the Synthesis of Membrane-localized D-peptide Inhibitors of HIV-1 Entry. Francis, J.N., J.S. Redman, D.M. Eckert, and M.S. Kay, Bioconjugate Chemistry, 2012. [Epub ahead of print]; PMID[22545664].

[PubMed]. HIV_0427-051012.

14. Identification of Novel HIV-1 Integrase Inhibitors Using Shape-based Screening, QSAR, and Docking Approach. Gupta, P., P. Garg, and N. Roy, Chemical Biology and Drug Design, 2012. 79(5): p. 835-849; PMID[22233531].

[PubMed]. HIV_0427-051012.

15. Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide. Harman, S., C. Herrera, N. Armanasco, J. Nuttall, and R.J. Shattock, Antimicrobial Agents and Chemotherapy, 2012. 56(5): p. 2347-2356; PMID[22330930].

[PubMed]. HIV_0427-051012.

16. Boosting of HIV Protease Inhibitors by Ritonavir in the Intestine: The Relative Role of Cyp and P-gp Inhibition Based on Caco-2 Monolayers Versus in Situ Intestinal Perfusion in Mice. Holmstock, N.F., P.P. Annaert, and P. Augustijns, Drug Metabolism and Disposition, 2012. [Epub ahead of print]; PMID[22550269].

[PubMed]. HIV_0427-051012.

17. Pentacycloundecane-diol-based HIV-1 Protease Inhibitors: Biological Screening, 2D NMR, and Molecular Simulation Studies. Honarparvar, B., M.M. Makatini, S.A. Pawar, K. Petzold, M.E. Soliman, P.I. Arvidsson, Y. Sayed, T. Govender, G.E. Maguire, and H.G. Kruger, ChemMedChem, 2012. [Epub ahead of print]; PMID[22544389].

[PubMed]. HIV_0427-051012.

18. A New Class of Synthetic Peptide Inhibitors Blocks Attachment and Entry of Human Pathogenic Viruses. Krepstakies, M., J. Lucifora, C.H. Nagel, M.B. Zeisel, B. Holstermann, H. Hohenberg, I. Kowalski, T. Gutsmann, T.F. Baumert, K. Brandenburg, J. Hauber, and U. Protzer, Journal of Infectious Disease, 2012. [Epub ahead of print]; PMID[22457281].

[PubMed]. HIV_0427-051012.

19. Old Plants Newly Discovered: Cassia sieberiana D.C. And Cassia abbreviata Oliv. Oliv. Root Extracts Inhibit in vitro HIV-1c Replication in Peripheral Blood Mononuclear Cells (PBMCs) by Different Modes of Action. Leteane, M.M., B.N. Ngwenya, M. Muzila, A. Namushe, J. Mwinga, R. Musonda, S. Moyo, Y.B. Mengestu, B.M. Abegaz, and K. Andrae-Marobela, Journal of Ethnopharmacology, 2012. 141(1): p. 48-56; PMID[22326358].

[PubMed]. HIV_0427-051012.

20. Synthesis, Drug Release and Anti-HIV Activity of a Series of PEGylated Zidovudine Conjugates. Li, W., J. Wu, P. Zhan, Y. Chang, C. Pannecouque, E. De Clercq, and X. Liu, International Journal of Biological Macromolecules, 2012. 50(4): p. 974-980; PMID[22390847].

[PubMed]. HIV_0427-051012.

21. Design and Synthesis of Novel Threosyl-5'- deoxyphosphonic Acid Purine Analogues as Potent Anti-HIV Agents. Liu, L.J., E. Kim, and J.H. Hong, Nucleosides Nucleotides Nucleic Acids, 2012. 31(5): p. 411-422; PMID[22497256].

[PubMed]. HIV_0427-051012.

22. IFN-Lambda3 Inhibits HIV Infection of Macrophages through the JAK-STAT Pathway. Liu, M.Q., D.J. Zhou, X. Wang, W. Zhou, L. Ye, J.L. Li, Y.Z. Wang, and W.Z. Ho, PLoS ONE, 2012. 7(4): p. e35902; PMID[22558263].

[PubMed]. HIV_0427-051012.

23. Sustained Release of the CCR5 Inhibitors CMPD167 and Maraviroc from Vaginal Rings in Rhesus Macaques. Malcolm, R.K., R.S. Veazey, L. Geer, D. Lowry, S.M. Fetherston, D.J. Murphy, P. Boyd, I. Major, R.J. Shattock, P.J. Klasse, L.A. Doyle, K.K. Rasmussen, L. Goldman, T.J. Ketas, and J.P. Moore, Antimicrobial Agents and Chemotherapy, 2012. 56(5): p. 2251-2258; PMID[22330914].

[PubMed]. HIV_0427-051012.

24. Docking, Molecular Dynamics and Quantitative Structure-Activity Relationship Studies for HEPTs and DABOs as HIV-1 Reverse Transcriptase Inhibitors. Mao, Y., Y. Li, M. Hao, S. Zhang, and C. Ai, Journal of Molecular Modeling, 2012. 18(5): p. 2185-2198; PMID[21947448].

[PubMed]. HIV_0427-051012.

25. Synthesis, Biological Activity and Docking Study of Imidazol-5-one as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Mokale, S.N., D. Lokwani, and D.B. Shinde, Bioorganic & Medicinal Chemistry, 2012. 20(9): p. 3119-3127; PMID[22480850].

[PubMed]. HIV_0427-051012.

26. UCLA1, a Synthetic Derivative of a gp120 RNA Aptamer, Inhibits Entry of Human Immunodeficiency Virus Type 1 Subtype C. Mufhandu, H.T., E.S. Gray, M.C. Madiga, N. Tumba, K.B. Alexandre, T. Khoza, C.K. Wibmer, P.L. Moore, L. Morris, and M. Khati, Journal of Virology, 2012. 86(9): p. 4989-4999; PMID[22379083].

[PubMed]. HIV_0427-051012.

27. In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068. Nowicka-Sans, B., Y.F. Gong, B. McAuliffe, I. Dicker, H.T. Ho, N. Zhou, B. Eggers, P.F. Lin, N. Ray, M. Wind-Rotolo, L. Zhu, A. Majumdar, D. Stock, M. Lataillade, G.J. Hanna, J.D. Matiskella, Y. Ueda, T. Wang, J.F. Kadow, N.A. Meanwell, and M. Krystal, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22547625].

[PubMed]. HIV_0427-051012.

28. Applications of 3-Aminolactams: Design, Synthesis, and Biological Evaluation of a Library of Potential Dimerisation Inhibitors of HIV1-protease. Pinyol, E., S. Frutos, D. Grillo-Bosch, E. Giralt, B. Clotet, J.A. Este, and A. Diez, Organic and Biomolecular Chemistry, 2012. [Epub ahead of print]; PMID[22546925].

[PubMed]. HIV_0427-051012.

29. Kinetic Mechanism for HIV-1 Neutralization by Antibody 2G12 Entails Reversible Glycan Binding That Slows Cell Entry. Platt, E.J., M.M. Gomes, and D. Kabat, Proceedings of the National Academy of Sciences of the United States of America, 2012. [Epub ahead of print]; PMID[22547820].

[PubMed]. HIV_0427-051012.

30. Lignosulfonic Acid Exhibits Broadly anti-HIV-1 activity - Potential as a Microbicide Candidate for the Prevention of HIV-1 Sexual Transmission. Qiu, M., Q. Wang, Y. Chu, Z. Yuan, H. Song, Z. Chen, and Z. Wu, PLoS ONE, 2012. 7(4): p. e35906; PMID[22558266].

[PubMed]. HIV_0427-051012.

31. Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors. Radi, M., M. Pagano, L. Franchi, D. Castagnolo, S. Schenone, G. Casaluce, C. Zamperini, E. Dreassi, G. Maga, A. Samuele, E. Gonzalo, B. Clotet, J.A. Este, and M. Botta, ChemMedChem, 2012. 7(5): p. 883-896; PMID[22419605].

[PubMed]. HIV_0427-051012.

32. Biological Activity of SE-10, Granulated Powder of Sasa aenanensis Rehder Leaf Extract. Sakagami, H., T. Matsuta, K. Satoh, S. Ohtsuki, C. Shimada, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Morita, A. Ohkubo, T. Tsuda, K. Sunaga, J. Maki, T. Sugiura, M. Kitajima, H. Oizumi, and T. Oizumi, In Vivo, 2012. 26(3): p. 411-418; PMID[22523293].

[PubMed]. HIV_0427-051012.

33. Target-selective Photodegradation of HIV-1 Protease and Inhibition of HIV-1 Replication in Living Cells by Designed Fullerene-sugar Hybrids. Tanimoto, S., S. Sakai, E. Kudo, S. Okada, S. Matsumura, D. Takahashi, and K. Toshima, Chemistry - An Asian Journal, 2012. 7(5): p. 911-914; PMID[22378594].

[PubMed]. HIV_0427-051012.

34. Discovery of Small Molecule HIV-1 Integrase Dimerization Inhibitors. Tintori, C., J. Demeulemeester, L. Franchi, S. Massa, Z. Debyser, F. Christ, and M. Botta, Bioorganic & Medicinal Chemistry Letters, 2012. 22(9): p. 3109-3114; PMID[22483582].

[PubMed]. HIV_0427-051012.

35. Blocking HIV-1 Entry by a gp120 Surface Binding Inhibitor. Tsou, L.K., C.H. Chen, G.E. Dutschman, Y.C. Cheng, and A.D. Hamilton, Bioorganic & Medicinal Chemistry Letters, 2012. 22(9): p. 3358-3361; PMID[22487177].

[PubMed]. HIV_0427-051012.

36. Preventing the Formation of P-TEFb by CycT1-Binding RNA Aptamer for anti-HIV Transcription. Um, H.J., M. Kim, S.H. Lee, and Y.H. Kim, AIDS, 2012. [Epub ahead of print]; PMID[22569018].

[PubMed]. HIV_0427-051012.

37. Treatment of SIV-infected Sooty Mangabeys with a Type-I IFN Agonist Results in Decreased Virus Replication without Inducing Hyper Immune Activation. Vanderford, T.H., C. Slichter, K.A. Rogers, B.O. Lawson, R. Obaede, J. Else, F. Villinger, S.E. Bosinger, and G. Silvestri, Blood, 2012. [Epub ahead of print]; PMID[22550346].

[PubMed]. HIV_0427-051012.

38. Ivermectin Is a Specific Inhibitor of Importin Alpha/Beta-mediated Nuclear Import able to Inhibit Replication of HIV-1 and Dengue Virus. Wagstaff, K.M., H. Sivakumaran, S.M. Heaton, D. Harrich, and D.A. Jans, Biochemistry Journal, 2012. 443(3): p. 851-856; PMID[22417684].

[PubMed]. HIV_0427-051012.

39. Biomimetic Oxidation of Aromatic Xenobiotics: Synthesis of the Phenolic Metabolites from the anti-HIV Drug Efavirenz. Wanke, R., D.A. Novais, S.G. Harjivan, M.M. Marques, and A.M. Antunes, Organic and Biomolecular Chemistry, 2012. [Epub ahead of print]; PMID[22569890].

[PubMed]. HIV_0427-051012.

40. Identification of Small Molecule Inhibitors of the HIV-1 Nucleocapsid-stem-loop 3 RNA Complex. Warui, D.M. and A.M. Baranger, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22480197].

[PubMed]. HIV_0427-051012.

41. Anti-AIDS Agents 89. Identification of DCX Derivatives as anti-HIV and Chemosensitizing Dual Function Agents to Overcome P-gp-mediated Drug Resistance for AIDS Therapy. Zhou, T., E. Ohkoshi, Q. Shi, K.F. Bastow, and K.H. Lee, Bioorganic and Medicinal Chemistry Letters, 2012. 22(9): p. 3219-3222; PMID[22465634].

[PubMed]. HIV_0427-051012.

42. New Active HIV-1 Protease Inhibitors Derived from 3-hexanol: Conformation Study of the Free Inhibitors in Crystalline State and in Complex with the Enzyme. Ziolkowska, N.E., A. Bujacz, R.S. Randad, J.W. Erickson, T. Skalova, J. Hasek, and G. Bujacz, Chemical Biology and Drug Design, 2012. 79(5): p. 798-809; PMID[22296826].

[PubMed]. HIV_0427-051012.

43. Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Targeting the Interaction between Vif and ElonginC. Zuo, T., D. Liu, W. Lv, X. Wang, J. Wang, M. Lv, W. Huang, J. Wu, H. Zhang, H. Jin, L. Zhang, W. Kong, and X. Yu, Journal of Virology, 2012. 86(10): p. 5497-5507; PMID[22379088].

[PubMed]. HIV_0427-051012.

ISI Web of Knowledge Citations

44. Synthesis and anti-HIV Activities of Glutamate and Peptide Conjugates of Nucleoside Reverse Transcriptase Inhibitors. Agarwa, H.K., B.S. Chhikara, M. Quiterio, G.F. Doncel, and K. Parang, Journal of Medicinal Chemistry, 2012. 55(6): p. 2672-2687; ISI[000301767000013].

[WOS]. HIV_0427-051012.

45. Phytochemical and Biological Studies of Ochna Species. Bandi, A.K.R., D.U. Lee, R.G. Tih, D. Gunasekar, and B. Bodo, Chemistry & Biodiversity, 2012. 9(2): p. 251-271; ISI[000300662300005].

[WOS]. HIV_0427-051012.

46. Diverse HIV Viruses are Targeted by a Conformationally Dynamic Antiviral. Caines, M.E.C., K. Bichel, A.J. Price, W.A. McEwan, G.J. Towers, B.J. Willett, S.M.V. Freund, and L.C. James, Nature Structural & Molecular Biology, 2012. 19(4): p. 411-416; ISI[000302514400008].

[WOS]. HIV_0427-051012.

47. Efficacy and Safety Tests of Long-acting Nanoformulated Anti-retroviral Drugs in HIV-1 Infected Humanized Mice. Dash, P.K., S. Gorantla, U. Roy, J. Knibbe, S. Balkundi, J. McMillan, H.A. Gelbard, L.Y. Poluektova, and H.E. Gendelman, Journal of Neuroimmune Pharmacology, 2012. 7: p. S14-S14; ISI[000302288800006].

[WOS]. HIV_0427-051012.

48. Fluorophosphonylated Nucleoside Derivatives as New Series of Thymidine Phosphorylase Multisubstrate Inhibitors. Diab, S.A., C. De Schutter, M. Muzard, R. Plantier-Royon, E. Pfund, and T. Lequeux, Journal of Medicinal Chemistry, 2012. 55(6): p. 2758-2768; ISI[000301767000020].

[WOS]. HIV_0427-051012.

49. Peptide Inhibitors of Viral Assembly: A Novel Route to Broad-spectrum Antivirals. ElSawy, K.M., R. Twarock, C.S. Verma, and L.S.D. Caves, Journal of Chemical Information and Modeling, 2012. 52(3): p. 770-776; ISI[000301884400012] .

[WOS]. HIV_0427-051012.

50. Two New 4-Hydroxyisoflavanes from the Root of Codonopsis cordifolioidea and Their Anti-virus Activities. Gao, X.M., H.X. Mu, X.S. Li, G.Y. Yang, G.P. Li, and Q.F. Hu, Journal of the Chinese Chemical Society, 2012. 59(4): p. 540-543; ISI[000302194400013].

[WOS]. HIV_0427-051012.

51. Antiretroviral Activity and Brain Penetrance of Folate-coated Nanoformulated Antiretroviral Drugs. Kanmogne, G.D., U. Roy, Z. Liu, J. McMillan, S. Gorantla, S. Balkundi, N. Smith, Y. Alnouti, N. Gautam, L. Poluektova, A. Kabanov, T. Bronich, and H.E. Gendelman, Journal of Neuroimmune Pharmacology, 2012. 7: p. S70-S71; ISI[000302288800170].

[WOS]. HIV_0427-051012.

52. Theranostic Developments of Small Magnetite Antiretroviral Particles-smart. Li, T., X. Liu, A.V. Kabanov, S. Kayandan, J.S. Riffle, H.E. Gendelman, S. Balasubramaniam, and R.M. Davis, Journal of Neuroimmune Pharmacology, 2012. 7: p. S43-S44; ISI[000302288800093].

[WOS]. HIV_0427-051012.

53. Synthesis, Characterization and Bioactivity Determination of Ferrocenyl Urea Derivatives. Liu, W., Y.T. Tang, Y. Guo, B. Sun, H.M. Zhu, Y.Y. Xiao, D.D. Dong, and C. Yang, Applied Organometallic Chemistry, 2012. 26(4): p. 189-193; ISI[000302006900007].

[WOS]. HIV_0427-051012.

54. Cystatin B Inhibits the IFN-Beta Response by Preventing STAT-1 Translocation and Decreasing Levels of STAT-1PY: Implication of HIV Replication in Macrophages. Rivera-Rivera, L., K. Colon, and L.M. Melendez, Journal of Neuroimmune Pharmacology, 2012. 7: p. S51-S51; ISI[000302288800115].

[WOS]. HIV_0427-051012.

55. Inhibition of Interferon Response by Cystatin B: Implication in HIV Replication of Macrophage Reservoirs. Rivera-Rivera, L., J. Perez-Laspiur, K. Colon, and L.M. Melendez, Journal of Neurovirology, 2012. 18(1): p. 20-29; ISI[000302246800003].

[WOS]. HIV_0427-051012.

56. Synthesis, X-Ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-based HIV-1 Protease Inhibitors. Wu, X.Y., P. Ohrngren, A.A. Joshi, A. Trejos, M. Persson, R.K. Arvela, H. Wallberg, L. Vrang, A. Rosenquist, B.B. Samuelsson, J. Unge, and M. Larhed, Journal of Medicinal Chemistry, 2012. 55(6): p. 2724-2736; ISI[000301767000017].

[WOS]. HIV_0427-051012.

57. Effect of Bond Linkage on in Vitro Drug Release and anti-HIV Activity of Chitosan-stavudine Conjugates. Zeng, R., Z.H. Wang, H.R. Wang, L.Q. Chen, L. Yang, R.Z. Qiao, L.M. Hu, and Z.L. Li, Macromolecular Research, 2012. 20(4): p. 358-365; ISI[000302297200005].

[WOS]. HIV_0427-051012.

Patent Citations

58. Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof. Chaiken, I., E. Papazoglou, A.R. Bastian, and Kantharaju. Patent. 2012. 2011-US54969 2012048033: 141pp.
[Patent]. HIV_0427-051012.

59. Dock-and-lock (Dnl) Constructs for Human Immunodeficiency Virus (HIV) Therapy. Chang, C.-H. and D.M. Goldenberg. Patent. 2012. 2011-288202 20120082685: 84pp.
[Patent]. HIV_0427-051012.

60. Compounds and Methods for Inhibiting HIV Latency. Karn, J., J. Friedman, and D.C.K. Chu. Patent. 2012. 2011-US56284 2012051492: 61pp.
[Patent]. HIV_0427-051012.

61. Modulators of Viral Transcription for Treatment of Human Immunodeficiency Virus (HIV) Infection. Kashanchi, F. Patent. 2012. 2011-162832 20120083498: 43pp.
[Patent]. HIV_0427-051012.

62. Thiazo(azine)lidone-azasugar Derivative with Fine anti-HIV Activity and Synthesis and Application Thereof in Pharmaceutical Preparation. Li, X., H. Chen, H. Zhang, Z. Qin, P. Zhang, Q. Yin, and J. Zhang. Patent. 2012. 2010-10293994 102417515: 22pp.
[Patent]. HIV_0427-051012.

63. Preparation of Amine Compound as CXCR4 Antagonist with anti-HIV Activity. Matsui, R., T. Yamazaki, and S. Kikumoto. Patent. 2012. 2011-JP72563 2012046653: 23pp.
[Patent]. HIV_0427-051012.

64. Nuclear Export Inhibitors to Inhibit Export of Antiviral and Tumor-suppressing Cellular Factors. Stauber, R., V. Fetz, S.K. Knauer, and W. Mann. Patent. 2012. 2011-EP66129 2012035147: 30pp.
[Patent]. HIV_0427-051012.

65. N-Alkyl or N-Aryl Substituted Guanide and Biguanide Compounds and Methods of Their Use. Teintze, M., R.A. Wilkinson, and M. Labib. Patent. 2012. 2011-US53401 2012047630: 117pp.
[Patent]. HIV_0427-051012.

66. Methods and Compositions Comprising Anti-Microtubule Compounds and Antiviral Agents for Reactivating a Latent Virus to Eradicate Viral Infections. Tsao, E.H.F., P. Kellam, and R.G. Jenner. Patent. 2012. 2011-GB51693 2012035321: 70pp.
[Patent]. HIV_0427-051012.

Meeting Citations

67. Grl-007: A Novel Small Molecule Ccr5 Antagonist Potent against a Wide Spectrum of HIV-1 Isolates. Nakata, H., D. Das, K. Maeda, K.V. Rao, A.K. Ghosh, and H. Mitsuya, 25th International Conference for Antiviral Research (ICAR - Japan), 2012. p. 22.
[ICAR]. HIV_0427-051012.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022